Two commonly used drugs for treating an enlarged prostate may increase the risk for Type 2 diabetes, according to new research led by Dr Li Wei (UCL School of Pharmacy). The risk is modest an extra 16 cases for every 1,000 men treated over 10 years - but nevertheless significant.
Read: New York Times